Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial
Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial
Active, not recruiting · NCT04333823 · Registry updated 2023-11-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperglycemia, immune system disorder, metabolic disease, type 1 diabetes mellitus | Active, not recruiting | Phase 3 | 2023-11-21 | NCT04333823 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Institutes of Health Research (CIHR) | 339 |
| Juvenile Diabetes Research Foundation | 33 |
| The Hospital for Sick Children | 162 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital Colorado Anschutz Medical Campus | Aurora | United States | 3 |
| London Health Sciences Centre Children's Hospital | London | Canada | 1 |
| The Hospital For Sick Children | Toronto | Canada | 94 |